UNOFFICIAL TRANSLATION:
Current report No. 36/2020
Date of preparation: 2020-05-26
Short name of the issuer: i2 Development S.A.
Subject: Selection of a new entity authorized to audit financial statements

Legal basis: Article 17 para. 1 MAR – confidential information.

In connection with current report number 57/2018 of 05/11/2018 regarding the selection of the entity authorized to audit financial statements for the years 2018-2019, the Management Board of i2 Development S.A. [hereinafter: the Company] informs that on 26.05.2020 the Company concluded with Grant Thornton Polska Spółka z ograniczoną odpowiedzialnością Spółka komandytowa with its registered office in Poznań entered into the list of entities authorized to audit under number 4055 a contract for the provision of following services:
• auditing the separate financial statements of i2 Development S.A. for 2020 and for 2021,
• auditing the consolidated financial statements of the i2 Development S.A. Capital Group for 2020 and for 2021,
• review of the interim separate financial statements of i2 Development S.A. for the first half of 2020 and for the first half of 2021,
• review of the interim consolidated financial statements of the i2 Development S.A. Capital Group for the first half of 2020 and for the first half of 2021.

The agreement was concluded on the basis of a decision of the Company’s Supervisory Board, which, acting on the basis of art. 382 § 1 of the Code of Commercial Companies and § 18 para. 3 lit. a) the Company’s Articles of Association, by resolution No. 1/V/2020 of May 21, 2020, made the selection of the above auditor to audit reports for the years 2020-2021. The Supervisory Board of the Company selected the entity authorized to audit financial statements in accordance with the Company’s Articles of Association and accepted corporate governance principles as well as in accordance with applicable regulations and professional standards.

Signatures of persons representing the Company:
2020-05-26   Marcin Misztal   President of the Management Board